Karyopharm Therapeutics Sets 2025 Shareholder Meeting
Ticker: KPTI · Form: DEF 14A · Filed: Dec 16, 2024 · CIK: 1503802
| Field | Detail |
|---|---|
| Company | Karyopharm Therapeutics Inc. (KPTI) |
| Form Type | DEF 14A |
| Filed Date | Dec 16, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: KPTI
TL;DR
Karyopharm (KPTI) proxy filed for Jan 30, 2025 meeting. Vote on company matters.
AI Summary
Karyopharm Therapeutics Inc. filed its definitive proxy statement for its 2025 annual meeting of stockholders, scheduled for January 30, 2025. The filing, made on December 16, 2024, outlines the agenda and proposals to be voted on by shareholders. The company is incorporated in Delaware and headquartered in Newton, MA.
Why It Matters
This filing is crucial for shareholders as it details the matters they will vote on, impacting the future direction and governance of Karyopharm Therapeutics.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing upcoming shareholder meeting information and not indicative of immediate financial risk.
Key Numbers
- 2025 — Annual Meeting Year (The proxy statement is for the 2025 annual meeting of stockholders.)
- January 30 — Meeting Date (The annual meeting is scheduled for January 30, 2025.)
Key Players & Entities
- Karyopharm Therapeutics Inc. (company) — Registrant
- January 30, 2025 (date) — Annual Meeting Date
- December 16, 2024 (date) — Filing Date
- Newton, MA (location) — Company Headquarters
FAQ
What is the purpose of this DEF 14A filing?
This DEF 14A filing is a definitive proxy statement for Karyopharm Therapeutics Inc.'s 2025 annual meeting of stockholders, detailing information for shareholders to vote on company matters.
When is the 2025 annual meeting of stockholders scheduled to take place?
The 2025 annual meeting of stockholders is scheduled for January 30, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on December 16, 2024.
Where is Karyopharm Therapeutics Inc. headquartered?
Karyopharm Therapeutics Inc. is headquartered at 85 Wells Avenue, Second Floor, Newton, MA 02459.
What is the fiscal year end for Karyopharm Therapeutics Inc.?
Karyopharm Therapeutics Inc.'s fiscal year ends on December 31.
Filing Stats: 4,841 words · 19 min read · ~16 pages · Grade level 12.4 · Accepted 2024-12-16 16:00:03
Key Financial Figures
- $1.00 — mmon stock had closed below the minimum $1.00 per share requirement for continued inc
Filing Documents
- kpti-_2025_spec_meeting-.htm (DEF 14A) — 396KB
- img220833156_0.jpg (GRAPHIC) — 33KB
- img220833156_1.jpg (GRAPHIC) — 9KB
- img220833156_2.jpg (GRAPHIC) — 465KB
- img220833156_3.jpg (GRAPHIC) — 402KB
- 0000950170-24-136598.txt ( ) — 1647KB
SECURITY OWNERSHIP OF BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF BENEFICIAL OWNERS AND MANAGEMENT 22 STOCKHOLDER PROPOSALS 24 STOCKHOLDERS SHARING THE SAME ADDRESS 25 OTHER MATTERS 25 APPENDIX A: Amendment to Restated Certificate of Incorporation A- 1 APPENDIX B: Amendment to Restated Certificate of Incorporation B- 1 Table of Contents PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON JANUARY 30, 2025 The Board of Directors (the “Board”) of Karyopharm Therapeutics Inc. (which we also refer to as “Karyopharm,” “the Company,” “we,” “us,” or “our”) is soliciting proxies for use at the Special Meeting of Stockholders (the “Special Meeting”), to be held exclusively online via the Internet as a virtual web conference at www.virtualshareholdermeeting.com/KPTI2025SM on January 30, 2025 at 9:00 a.m. Eastern Time. We have determined that the Special Meeting will be held in a virtual meeting format only, via the Internet, with no physical in-person meeting. At our virtual Special Meeting, stockholders will be able to attend, vote and submit questions by visiting www.virtualshareholdermeeting.com/KPTI2025SM . Further information about how to attend the Special Meeting online, vote your shares online during the Special Meeting and submit questions during the Special Meeting is included in this proxy statement. Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be Held on January 30, 2025: This proxy statement is available electronically at www.proxyvote.com . A printed copy of our proxy materials, including proxy card, is being mailed to our stockholders on December 16, 2024 and sent by e-mail to our stockholders who have opted for such means of delivery on or about December 16, 2024. 1 Table of Contents GENERAL INFORMATION ABOUT THIS PROXY STATEMENT, THE SPECIAL MEETING AND VOTING Why is the Company holding